Introduction The development of oncology medicine continues because targeted therapy emerges as a central method to handle cancer types across different categories. The unique design of targeted therapies works differently...
Introduction Alpha and beta cancers rank as the leading form of malignancy worldwide because they produce fresh cases in millions annually. Public health outcomes strengthen when medical access occurs early...
Molecular biomarkers have opened a new chapter in the field of oncology with new protocols in treatment moving more towards individualized therapy. Biomarkers are defined as objective signs of certain...
It is a chronic myeloproliferative disorder characterized by the proliferation of the megakaryocytic lineage and the production of platelets that are higher than normal. ET is defined specifically based on...
Cancer diagnosis has in the past required using procedures that included tissue biopsy, where though they are effective, the patient experiences a lot of discomfort. In the last few decades,...
